论文部分内容阅读
雷佛奴尔作为宫腔内引产药物在我国起自1951年。近2年来,国内广泛使用雷佛奴尔羊膜腔内注入进行中期引产,收到疗效好、安全、简单的效果。我校妇产科与海口市妇幼保健院从1979后10月开始用1%雷佛奴尔10ml羊膜腔内注入,进行中期引产140例,成功率达98.5%,未发现有严重感染现象。本文收集38例引产之胎儿及其附属物,进行病理形态学研究。并与双目灵,高渗盐水羊膜腔注入引产,自然流产之胎盘、脐带等病理改变相比较,探讨雷佛奴尔引产的原理。
Leifuole as intrauterine induction of labor drugs in our country since 1951. The past two years, the widespread use of intracranial injection of Leifnor amniotic fluid mid-term induction, received a good effect, safe and simple effect. Department of Obstetrics and Gynecology, Haikou City, MCH and IMC started from October 1979 with 1% Levernor 10ml amniotic cavity injection, mid-term induction of labor in 140 cases, the success rate of 98.5%, did not find a serious infection. In this paper, 38 fetuses and their appendages were collected for pathological study. And binocular, hypertonic saline amniotic cavity injection of induced abortion, placenta abortion and umbilical cord and other pathological changes compared to explore the principle of Leifnull induced labor.